Advanced Drug Delivery Reviews, volume 130, pages 73-89
Harnessing albumin as a carrier for cancer therapies
1
Department of Biomedical Engineering Vanderbilt University Nashville TN
|
Publication type: Journal Article
Publication date: 2018-05-01
Journal:
Advanced Drug Delivery Reviews
Quartile SCImago
Q1
Quartile WOS
Q1
Impact factor: 16.1
ISSN: 0169409X, 18728294
PubMed ID:
30012492
Pharmaceutical Science
Abstract
Serum albumin, a natural ligand carrier that is highly concentrated and long-circulating in the blood, has shown remarkable promise as a carrier for anti-cancer agents. Albumin is able to prolong the circulation half-life of otherwise rapidly cleared drugs and, importantly, promote their accumulation within tumors. The applications for using albumin as a cancer drug carrier are broad and include both traditional cancer chemotherapeutics and new classes of biologics. Strategies for leveraging albumin for drug delivery can be classified broadly into exogenous and in situ binding formulations that utilize covalent attachment, non-covalent association, or encapsulation in albumin-based nanoparticles. These methods have shown remarkable preclinical and clinical successes that are examined in this review.
Citations by journals
|
2
4
6
8
10
12
|
|
|
Journal of Controlled Release
|
Journal of Controlled Release
12 publications, 3.36%
|
|
Pharmaceutics
|
Pharmaceutics
11 publications, 3.08%
|
|
International Journal of Molecular Sciences
|
International Journal of Molecular Sciences
10 publications, 2.8%
|
|
International Journal of Biological Macromolecules
|
International Journal of Biological Macromolecules
8 publications, 2.24%
|
|
Journal of the American Chemical Society
|
Journal of the American Chemical Society
7 publications, 1.96%
|
|
Molecular Pharmaceutics
|
Molecular Pharmaceutics
7 publications, 1.96%
|
|
Advanced Drug Delivery Reviews
|
Advanced Drug Delivery Reviews
6 publications, 1.68%
|
|
Molecules
|
Molecules
5 publications, 1.4%
|
|
Cancers
|
Cancers
5 publications, 1.4%
|
|
ACS applied materials & interfaces
|
ACS applied materials & interfaces
5 publications, 1.4%
|
|
Chemical Communications
|
Chemical Communications
4 publications, 1.12%
|
|
Nano Research
|
Nano Research
4 publications, 1.12%
|
|
Frontiers in Immunology
|
Frontiers in Immunology
4 publications, 1.12%
|
|
International Journal of Pharmaceutics
|
International Journal of Pharmaceutics
4 publications, 1.12%
|
|
Journal of Inorganic Biochemistry
|
Journal of Inorganic Biochemistry
4 publications, 1.12%
|
|
Chemical Engineering Journal
|
Chemical Engineering Journal
4 publications, 1.12%
|
|
Biomaterials
|
Biomaterials
4 publications, 1.12%
|
|
European Journal of Pharmaceutical Sciences
|
European Journal of Pharmaceutical Sciences
4 publications, 1.12%
|
|
Inorganic Chemistry
|
Inorganic Chemistry
4 publications, 1.12%
|
|
ACS Nano
|
ACS Nano
4 publications, 1.12%
|
|
ACS Omega
|
ACS Omega
4 publications, 1.12%
|
|
Nano Letters
|
Nano Letters
3 publications, 0.84%
|
|
Polymers
|
Polymers
3 publications, 0.84%
|
|
Frontiers in Pharmacology
|
Frontiers in Pharmacology
3 publications, 0.84%
|
|
European Journal of Pharmaceutics and Biopharmaceutics
|
European Journal of Pharmaceutics and Biopharmaceutics
3 publications, 0.84%
|
|
Colloids and Surfaces B: Biointerfaces
|
Colloids and Surfaces B: Biointerfaces
3 publications, 0.84%
|
|
Journal of Drug Delivery Science and Technology
|
Journal of Drug Delivery Science and Technology
3 publications, 0.84%
|
|
Acta Biomaterialia
|
Acta Biomaterialia
3 publications, 0.84%
|
|
Advanced Functional Materials
|
Advanced Functional Materials
3 publications, 0.84%
|
|
2
4
6
8
10
12
|
Citations by publishers
|
20
40
60
80
100
120
|
|
|
Elsevier
|
Elsevier
101 publications, 28.29%
|
|
American Chemical Society (ACS)
|
American Chemical Society (ACS)
57 publications, 15.97%
|
|
Multidisciplinary Digital Publishing Institute (MDPI)
|
Multidisciplinary Digital Publishing Institute (MDPI)
46 publications, 12.89%
|
|
Wiley
|
Wiley
30 publications, 8.4%
|
|
Springer Nature
|
Springer Nature
30 publications, 8.4%
|
|
Royal Society of Chemistry (RSC)
|
Royal Society of Chemistry (RSC)
20 publications, 5.6%
|
|
Frontiers Media S.A.
|
Frontiers Media S.A.
11 publications, 3.08%
|
|
Taylor & Francis
|
Taylor & Francis
7 publications, 1.96%
|
|
Dove Medical Press
|
Dove Medical Press
5 publications, 1.4%
|
|
American Society for Pharmacology and Experimental Therapeutics
|
American Society for Pharmacology and Experimental Therapeutics
3 publications, 0.84%
|
|
Bentham Science
|
Bentham Science
3 publications, 0.84%
|
|
Future Medicine
|
Future Medicine
2 publications, 0.56%
|
|
American Association for Cancer Research (AACR)
|
American Association for Cancer Research (AACR)
2 publications, 0.56%
|
|
Center of Pharmaceutical Analytics Ltd
|
Center of Pharmaceutical Analytics Ltd
1 publication, 0.28%
|
|
Beilstein-Institut
|
Beilstein-Institut
1 publication, 0.28%
|
|
Mary Ann Liebert
|
Mary Ann Liebert
1 publication, 0.28%
|
|
Spandidos Publications
|
Spandidos Publications
1 publication, 0.28%
|
|
SAGE
|
SAGE
1 publication, 0.28%
|
|
Pharmaceutical Society of Korea
|
Pharmaceutical Society of Korea
1 publication, 0.28%
|
|
Korean Society for Biotechnology and Bioengineering
|
Korean Society for Biotechnology and Bioengineering, 1, 0.28%
Korean Society for Biotechnology and Bioengineering
1 publication, 0.28%
|
|
King Saud University
|
King Saud University
1 publication, 0.28%
|
|
IOP Publishing
|
IOP Publishing
1 publication, 0.28%
|
|
PeerJ
|
PeerJ
1 publication, 0.28%
|
|
BMJ
|
BMJ
1 publication, 0.28%
|
|
American Association for the Advancement of Science (AAAS)
|
American Association for the Advancement of Science (AAAS)
1 publication, 0.28%
|
|
Hindawi Limited
|
Hindawi Limited
1 publication, 0.28%
|
|
American Institute of Physics (AIP)
|
American Institute of Physics (AIP)
1 publication, 0.28%
|
|
Pleiades Publishing
|
Pleiades Publishing
1 publication, 0.28%
|
|
AME Publishing Company
|
AME Publishing Company
1 publication, 0.28%
|
|
20
40
60
80
100
120
|
- We do not take into account publications that without a DOI.
- Statistics recalculated only for publications connected to researchers, organizations and labs registered on the platform.
- Statistics recalculated weekly.
{"yearsCitations":{"type":"bar","data":{"show":true,"labels":[2018,2019,2020,2021,2022,2023,2024],"ids":[0,0,0,0,0,0,0],"codes":[0,0,0,0,0,0,0],"imageUrls":["","","","","","",""],"datasets":[{"label":"Citations number","data":[2,22,31,83,93,93,33],"backgroundColor":["#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6"],"percentage":["0.56","6.16","8.68","23.25","26.05","26.05","9.24"],"barThickness":null}]},"options":{"indexAxis":"x","maintainAspectRatio":true,"scales":{"y":{"ticks":{"precision":0,"autoSkip":false,"font":{"family":"Montserrat"},"color":"#000000"}},"x":{"ticks":{"stepSize":1,"precision":0,"font":{"family":"Montserrat"},"color":"#000000"}}},"plugins":{"legend":{"position":"top","labels":{"font":{"family":"Montserrat"},"color":"#000000"}},"title":{"display":true,"text":"Citations per year","font":{"size":24,"family":"Montserrat","weight":600},"color":"#000000"}}}},"journals":{"type":"bar","data":{"show":true,"labels":["Journal of Controlled Release","Pharmaceutics","International Journal of Molecular Sciences","International Journal of Biological Macromolecules","Journal of the American Chemical Society","Molecular Pharmaceutics","Advanced Drug Delivery Reviews","Molecules","Cancers","ACS applied materials & interfaces","Chemical Communications","Nano Research","Frontiers in Immunology","International Journal of Pharmaceutics","Journal of Inorganic Biochemistry","Chemical Engineering Journal","Biomaterials","European Journal of Pharmaceutical Sciences","Inorganic Chemistry","ACS Nano","ACS Omega","Nano Letters","Polymers","Frontiers in Pharmacology","European Journal of Pharmaceutics and Biopharmaceutics","Colloids and Surfaces B: Biointerfaces","Journal of Drug Delivery Science and Technology","Acta Biomaterialia","Advanced Functional Materials"],"ids":[14351,4502,14627,23035,4813,19735,12266,1770,22471,1458,9073,12211,1699,3305,6830,16275,13732,9338,24714,8724,18901,10312,11204,9788,25165,2020,17907,9874,7715],"codes":[0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0],"imageUrls":["\/storage\/images\/resized\/GDnYOu1UpMMfMMRV6Aqle4H0YLLsraeD9IP9qScG_medium.webp","\/storage\/images\/resized\/MjH1ITP7lMYGxeqUZfkt2BnVLgjkk413jwBV97XX_medium.webp","\/storage\/images\/resized\/MjH1ITP7lMYGxeqUZfkt2BnVLgjkk413jwBV97XX_medium.webp","\/storage\/images\/resized\/GDnYOu1UpMMfMMRV6Aqle4H0YLLsraeD9IP9qScG_medium.webp","\/storage\/images\/resized\/iLiQsFqFaSEx6chlGQ5fbAwF6VYU3WWa08hkss0g_medium.webp","\/storage\/images\/resized\/iLiQsFqFaSEx6chlGQ5fbAwF6VYU3WWa08hkss0g_medium.webp","\/storage\/images\/resized\/GDnYOu1UpMMfMMRV6Aqle4H0YLLsraeD9IP9qScG_medium.webp","\/storage\/images\/resized\/MjH1ITP7lMYGxeqUZfkt2BnVLgjkk413jwBV97XX_medium.webp","\/storage\/images\/resized\/MjH1ITP7lMYGxeqUZfkt2BnVLgjkk413jwBV97XX_medium.webp","\/storage\/images\/resized\/iLiQsFqFaSEx6chlGQ5fbAwF6VYU3WWa08hkss0g_medium.webp","\/storage\/images\/resized\/leiAYcRDGTSl5B1eCnwpSGqmDEUEfDPPoYisFGhT_medium.webp","\/storage\/images\/resized\/voXLqlsvTwv5p3iMQ8Dhs95nqB4AXOG7Taj7G4ra_medium.webp","\/storage\/images\/resized\/4QWA67eqfcfyOiA8Wk7YnqroHFqQbTsmDJUYTCTg_medium.webp","\/storage\/images\/resized\/GDnYOu1UpMMfMMRV6Aqle4H0YLLsraeD9IP9qScG_medium.webp","\/storage\/images\/resized\/GDnYOu1UpMMfMMRV6Aqle4H0YLLsraeD9IP9qScG_medium.webp","\/storage\/images\/resized\/GDnYOu1UpMMfMMRV6Aqle4H0YLLsraeD9IP9qScG_medium.webp","\/storage\/images\/resized\/GDnYOu1UpMMfMMRV6Aqle4H0YLLsraeD9IP9qScG_medium.webp","\/storage\/images\/resized\/GDnYOu1UpMMfMMRV6Aqle4H0YLLsraeD9IP9qScG_medium.webp","\/storage\/images\/resized\/iLiQsFqFaSEx6chlGQ5fbAwF6VYU3WWa08hkss0g_medium.webp","\/storage\/images\/resized\/iLiQsFqFaSEx6chlGQ5fbAwF6VYU3WWa08hkss0g_medium.webp","\/storage\/images\/resized\/iLiQsFqFaSEx6chlGQ5fbAwF6VYU3WWa08hkss0g_medium.webp","\/storage\/images\/resized\/iLiQsFqFaSEx6chlGQ5fbAwF6VYU3WWa08hkss0g_medium.webp","\/storage\/images\/resized\/MjH1ITP7lMYGxeqUZfkt2BnVLgjkk413jwBV97XX_medium.webp","\/storage\/images\/resized\/4QWA67eqfcfyOiA8Wk7YnqroHFqQbTsmDJUYTCTg_medium.webp","\/storage\/images\/resized\/GDnYOu1UpMMfMMRV6Aqle4H0YLLsraeD9IP9qScG_medium.webp","\/storage\/images\/resized\/GDnYOu1UpMMfMMRV6Aqle4H0YLLsraeD9IP9qScG_medium.webp","\/storage\/images\/resized\/GDnYOu1UpMMfMMRV6Aqle4H0YLLsraeD9IP9qScG_medium.webp","\/storage\/images\/resized\/GDnYOu1UpMMfMMRV6Aqle4H0YLLsraeD9IP9qScG_medium.webp","\/storage\/images\/resized\/bRyGpdm98BkAUYiK1YFNpl5Z7hPu6Gd87gbIeuG3_medium.webp"],"datasets":[{"label":"","data":[12,11,10,8,7,7,6,5,5,5,4,4,4,4,4,4,4,4,4,4,4,3,3,3,3,3,3,3,3],"backgroundColor":["#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6"],"percentage":[3.36,3.08,2.8,2.24,1.96,1.96,1.68,1.4,1.4,1.4,1.12,1.12,1.12,1.12,1.12,1.12,1.12,1.12,1.12,1.12,1.12,0.84,0.84,0.84,0.84,0.84,0.84,0.84,0.84],"barThickness":13}]},"options":{"indexAxis":"y","maintainAspectRatio":false,"scales":{"y":{"ticks":{"precision":0,"autoSkip":false,"font":{"family":"Montserrat"},"color":"#000000"}},"x":{"ticks":{"stepSize":null,"precision":0,"font":{"family":"Montserrat"},"color":"#000000"}}},"plugins":{"legend":{"position":"top","labels":{"font":{"family":"Montserrat"},"color":"#000000"}},"title":{"display":true,"text":"Journals","font":{"size":24,"family":"Montserrat","weight":600},"color":"#000000"}}}},"publishers":{"type":"bar","data":{"show":true,"labels":["Elsevier","American Chemical Society (ACS)","Multidisciplinary Digital Publishing Institute (MDPI)","Wiley","Springer Nature","Royal Society of Chemistry (RSC)","Frontiers Media S.A.","Taylor & Francis","Dove Medical Press","American Society for Pharmacology and Experimental Therapeutics","Bentham Science","Future Medicine","American Association for Cancer Research (AACR)","Center of Pharmaceutical Analytics Ltd","Beilstein-Institut","Mary Ann Liebert","Spandidos Publications","SAGE","Pharmaceutical Society of Korea","Korean Society for Biotechnology and Bioengineering","King Saud University","IOP Publishing","PeerJ","BMJ","American Association for the Advancement of Science (AAAS)","Hindawi Limited","American Institute of Physics (AIP)","Pleiades Publishing","AME Publishing Company"],"ids":[17,40,202,11,8,123,208,18,417,695,39,6949,2286,7156,6139,230,1097,31,8825,2287,171,2075,1089,6954,189,6921,250,101,1566],"codes":[0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0],"imageUrls":["\/storage\/images\/resized\/GDnYOu1UpMMfMMRV6Aqle4H0YLLsraeD9IP9qScG_medium.webp","\/storage\/images\/resized\/iLiQsFqFaSEx6chlGQ5fbAwF6VYU3WWa08hkss0g_medium.webp","\/storage\/images\/resized\/MjH1ITP7lMYGxeqUZfkt2BnVLgjkk413jwBV97XX_medium.webp","\/storage\/images\/resized\/bRyGpdm98BkAUYiK1YFNpl5Z7hPu6Gd87gbIeuG3_medium.webp","\/storage\/images\/resized\/voXLqlsvTwv5p3iMQ8Dhs95nqB4AXOG7Taj7G4ra_medium.webp","\/storage\/images\/resized\/leiAYcRDGTSl5B1eCnwpSGqmDEUEfDPPoYisFGhT_medium.webp","\/storage\/images\/resized\/4QWA67eqfcfyOiA8Wk7YnqroHFqQbTsmDJUYTCTg_medium.webp","\/storage\/images\/resized\/5YZtvLvkPZuc2JHOaZsjCvGSHFCuC3drUwN3YAc5_medium.webp","\/storage\/images\/resized\/wVWp6zaxUsMdR03dYMdOZoesUrVGtNMWkHKByIvT_medium.webp","\/storage\/images\/resized\/s6JtNKPXrzklKtbQZ4HrtzuJT0P7eHPX9U8x0nss_medium.webp","\/storage\/images\/resized\/doUaFUZdxUEQjLi1TwZjGHi8HXYNWWSk04dSC6Xh_medium.webp","\/storage\/images\/resized\/AN2jnDN59NmKaS4CWLHAGstADL2DbnatQScsFA6C_medium.webp","\/storage\/images\/resized\/cfuVw6XIq2mATDNJdXiose3W8qYbkmaVSpHoP8XL_medium.webp","\/storage\/images\/resized\/ewwj5yBvA6wToa4jkXRrcDjN2omUCp6UYltwKhS8_medium.webp","\/storage\/images\/resized\/ex6KJoZujZOZFZh7jGfeHauiftuB3CI7iwJVFRDg_medium.webp","\/storage\/images\/resized\/Zy5YST233rzRbZP24I24MzZm64hz20ZV9qQopmMn_medium.webp","\/storage\/images\/resized\/8zKfOwdd5XirYzTQfqwp7U8IEQc8ckIOjyYQSBkk_medium.webp","\/storage\/images\/resized\/ruydfaB80LDjlkYqsfOeUAZohOIODyq7bQzis5O7_medium.webp","\/storage\/images\/resized\/orXcZtXpI7UpnWWqQEfW5ZNVoteL6CqvOi1ztUcD_medium.webp","","\/storage\/images\/resized\/9z7b0TQJNgUxZHYXLrTmbnjJn9y5iq56Wxtqb1Lv_medium.webp","\/storage\/images\/resized\/LsKy6OnmmmRGcAU6CZgWQvNiP1polbaSLNrN7zqj_medium.webp","\/storage\/images\/resized\/aOPqEqNWK2Sq9T8CLDlsR6diWsFkHppx3bLsAnpx_medium.webp","\/storage\/images\/resized\/hysFKdIDQMKHPbF1uLxJ3M6dQA4gPVuC6ZeA7m5a_medium.webp","\/storage\/images\/resized\/s10mcsCV4OAUg9O2KrqOquQC0PhyLMI8hUUkuflM_medium.webp","\/storage\/images\/resized\/hqfzhQAjTGlNSRs6yzFNITgjSMm9Jr2QuotJHIvE_medium.webp","\/storage\/images\/resized\/ARM4e6URKRsbRZvIF0vFis9DjxGloBjnBYJXbHmZ_medium.webp","\/storage\/images\/resized\/oZgeErrVFhuDksyqFURLvYS1wtVSBWczh001igGo_medium.webp","\/storage\/images\/resized\/PYBAYQjpFdxPQPRGY3kU5Xzbu0W7K7umVNk0TY9i_medium.webp"],"datasets":[{"label":"","data":[101,57,46,30,30,20,11,7,5,3,3,2,2,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1,1],"backgroundColor":["#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6"],"percentage":[28.29,15.97,12.89,8.4,8.4,5.6,3.08,1.96,1.4,0.84,0.84,0.56,0.56,0.28,0.28,0.28,0.28,0.28,0.28,0.28,0.28,0.28,0.28,0.28,0.28,0.28,0.28,0.28,0.28],"barThickness":13}]},"options":{"indexAxis":"y","maintainAspectRatio":false,"scales":{"y":{"ticks":{"precision":0,"autoSkip":false,"font":{"family":"Montserrat"},"color":"#000000"}},"x":{"ticks":{"stepSize":null,"precision":0,"font":{"family":"Montserrat"},"color":"#000000"}}},"plugins":{"legend":{"position":"top","labels":{"font":{"family":"Montserrat"},"color":"#000000"}},"title":{"display":true,"text":"Publishers","font":{"size":24,"family":"Montserrat","weight":600},"color":"#000000"}}}}}
Metrics
Cite this
GOST |
RIS |
BibTex
Cite this
GOST
Copy
Hoogenboezem E. N., Duvall C. L. Harnessing albumin as a carrier for cancer therapies // Advanced Drug Delivery Reviews. 2018. Vol. 130. pp. 73-89.
GOST all authors (up to 50)
Copy
Hoogenboezem E. N., Duvall C. L. Harnessing albumin as a carrier for cancer therapies // Advanced Drug Delivery Reviews. 2018. Vol. 130. pp. 73-89.
Cite this
RIS
Copy
TY - JOUR
DO - 10.1016/j.addr.2018.07.011
UR - https://doi.org/10.1016%2Fj.addr.2018.07.011
TI - Harnessing albumin as a carrier for cancer therapies
T2 - Advanced Drug Delivery Reviews
AU - Hoogenboezem, Ella N
AU - Duvall, Craig L
PY - 2018
DA - 2018/05/01 00:00:00
PB - Elsevier
SP - 73-89
VL - 130
PMID - 30012492
SN - 0169-409X
SN - 1872-8294
ER -
Cite this
BibTex
Copy
@article{2018_Hoogenboezem,
author = {Ella N Hoogenboezem and Craig L Duvall},
title = {Harnessing albumin as a carrier for cancer therapies},
journal = {Advanced Drug Delivery Reviews},
year = {2018},
volume = {130},
publisher = {Elsevier},
month = {may},
url = {https://doi.org/10.1016%2Fj.addr.2018.07.011},
pages = {73--89},
doi = {10.1016/j.addr.2018.07.011}
}